<DOC>
	<DOCNO>NCT01823926</DOCNO>
	<brief_summary>Introduction : Inhalation therapy establish efficient route treat asthma exacerbation , couple noninvasive ventilation ( NIV ) remain quite challenge . Objectives : The aim study compare radiaoaerosol pulmonary index radioaerosol mass balance different compartment ( pulmonary extrapulmonary ) use vibrate mesh nebulizer ( VMN ) jet nebulizer ( JN ) couple noninvasive ventilation ( NIV ) . Material method : The investigator assess 10 stable moderate severe asthmatic crossover study . Patients randomly assign participate phase study : Phase 1 ( NIV+MN ) phase 2 ( NIV+JN ) . DTPA-Tc99m radioactivity 25 miC use inhaler use JN position circuit use `` T '' piece , particle size generation five micron range oxygen flow tritated eight L/min MN position mask , particle size generation one range connect electrical energy . NIV use bilevel pressure face mask attach strap pressure adjust 12 cmH2O 5 cmH2O inspiratory expiratory pressure , respectively . After , radioactivity count perform use gama camera region interest delimit . To calculate aerosol mass balance investigator consider amount radioaerosol deposit lung , upper airway , stomach , nebulizer , circuit , inspiratory expiratory filter , mask divide compartment represent percentage .</brief_summary>
	<brief_title>Asthma Quantifying Delivery Of Radio Labeled Aerosol</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>stable moderate severe asthma ( FEV1 &gt; 60 % &gt; 80 % PEF variation 30 % predict value moderate FVE1 &gt; 60 % ) ; More one year elapse since diagnosis asthma ; None exacerbation last six month ; Age 18 60 year , sex , Able understand verbal command Consent participate protocol . presence dyspnea ; smoke history ; cardiopulmonary disease ( chronic obstructive pulmonary disease , pneumonia , cardiac failure , myocardial infarction , pneumothorax ) ; hyperthermia ; hemodynamic instability ( heart rate &gt; 150 bpm systolic blood pressure &lt; 90 mmHg ) ; arrhythmia absence ; pregnancy contraindication use noninvasive ventilation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>vibrate mesh nebulizer</keyword>
	<keyword>noninvasive ventilation</keyword>
	<keyword>residual volume</keyword>
	<keyword>pulmonary scintigraphy</keyword>
	<keyword>radioaerosol</keyword>
	<keyword>nebulization .</keyword>
</DOC>